Lastest Insider Transactions Of Travere Therapeutics, Inc. ( TVTX )
SymbolCompany NameInsider NameTitleDateTransationSharePriceAmountFile Date
TVTXTravere Therapeutics, Inc.LYONS GARY ADirectior2024-10-04Sell40,00014.73589,1012024-10-04 19:15:51
TVTXTravere Therapeutics, Inc.LYONS GARY ADirectior2024-10-04Option Exercise40,00010.48419,2002024-10-04 19:15:51
TVTXTravere Therapeutics, Inc.Meckler Jeffrey ADirectior2024-09-30Sell40,00014.06562,3242024-09-30 20:38:12
TVTXTravere Therapeutics, Inc.Meckler Jeffrey ADirectior2024-09-30Option Exercise40,00010.48419,2002024-09-30 20:38:12
TVTXTravere Therapeutics, Inc.Cline Christopher R.CHIEF FINANCIAL OFFICER2024-04-11Sell546.743642024-04-12 16:05:08
TVTXTravere Therapeutics, Inc.Dube Eric MCHIEF EXECUTIVE OFFICER2024-01-31Sell19,1228.70166,4352024-02-02 16:06:01
TVTXTravere Therapeutics, Inc.ROTE WILLIAM E.SENIOR VICE PRESIDENT, R&D2024-01-31Sell4,7648.7141,4952024-02-02 16:05:41
TVTXTravere Therapeutics, Inc.Calvin SandraSVP, CHIEF ACCOUNTING OFFICER2024-01-31Sell2,8208.5324,0582024-02-02 16:05:37
TVTXTravere Therapeutics, Inc.REED ELIZABETH ESVP, GC & CORPORATE SECRETARY2024-01-31Sell4,7648.7141,4952024-02-02 16:05:35
TVTXTravere Therapeutics, Inc.Heerma PeterCHIEF COMMERCIAL OFFICER2024-01-31Sell4,1958.5335,7892024-02-02 16:05:34
TVTXTravere Therapeutics, Inc.Inrig JulaCHIEF MEDICAL OFFICER2024-01-31Sell2,1748.5318,5472024-02-02 16:05:27
TVTXTravere Therapeutics, Inc.Cline Christopher R.CHIEF FINANCIAL OFFICER2024-01-31Sell3,8188.5332,5732024-02-02 16:05:22
TVTXTravere Therapeutics, Inc.REED ELIZABETH ESVP, GC & CORPORATE SECRETARY2024-01-23Sell2,0628.9618,4762024-01-25 16:10:27
TVTXTravere Therapeutics, Inc.Dube Eric MCHIEF EXECUTIVE OFFICER2024-01-23Sell7,8738.9670,5422024-01-25 16:10:21
TVTXTravere Therapeutics, Inc.Cline Christopher R.CHIEF FINANCIAL OFFICER2024-01-23Sell8539.077,7352024-01-25 16:10:17
TVTXTravere Therapeutics, Inc.ROTE WILLIAM E.SENIOR VICE PRESIDENT, R&D2024-01-23Sell2,0628.9618,4762024-01-25 16:10:16
TVTXTravere Therapeutics, Inc.Calvin SandraSVP, CHIEF ACCOUNTING OFFICER2024-01-23Sell9109.078,2522024-01-25 16:10:12
TVTXTravere Therapeutics, Inc.Heerma PeterCHIEF COMMERCIAL OFFICER2024-01-23Sell1,5599.0714,1382024-01-25 16:10:11
TVTXTravere Therapeutics, Inc.Inrig JulaChief Medical Officer2024-01-03Sell2,5099.4323,6482024-01-05 16:11:49
TVTXTravere Therapeutics, Inc.Heerma PeterChief Commercial Officer2023-10-03Sell3,0918.2525,5042023-10-04 16:05:09
TVTXTravere Therapeutics, Inc.Cline Christopher R.Chief Financial Officer2023-09-05Sell45714.716,7232023-09-05 20:15:39
TVTXTravere Therapeutics, Inc.ROTE WILLIAM E.Senior Vice President, R&D2023-08-31Sell1,81514.7126,6992023-09-05 20:13:54
TVTXTravere Therapeutics, Inc.REED ELIZABETH ESVP, GC & Corporate Secretary2023-08-31Sell1,81514.7126,6992023-09-05 20:12:15
TVTXTravere Therapeutics, Inc.Dube Eric MChief Executive Officer2023-08-31Sell4,45514.7165,5332023-09-05 20:10:08
TVTXTravere Therapeutics, Inc.Cline Christopher R.Chief Financial Officer2023-05-10Sell45516.597,5482023-05-12 16:14:19
TVTXTravere Therapeutics, Inc.REED ELIZABETH ESVP, GC & Corporate Secretary2023-05-10Sell82516.5913,6872023-05-12 16:11:57
TVTXTravere Therapeutics, Inc.ROTE WILLIAM E.Senior Vice President, R&D2023-05-10Sell82516.5913,6872023-05-12 16:09:22
TVTXTravere Therapeutics, Inc.Calvin SandraSVP, Chief Accounting Officer2023-05-10Sell55816.499,2002023-05-12 16:06:20
TVTXTravere Therapeutics, Inc.Cline Christopher R.Chief Financial Officer2023-04-11Sell4721.491,0102023-04-13 16:07:27
TVTXTravere Therapeutics, Inc.REED ELIZABETH ESVP, GC & Corporate Secretary2023-01-31Sell2,59022.2557,6282023-02-02 19:11:10
TVTXTravere Therapeutics, Inc.ROTE WILLIAM E.Senior Vice President, R&D2023-01-31Sell2,59022.2557,6282023-02-02 19:08:39
TVTXTravere Therapeutics, Inc.Heerma PeterChief Commercial Officer2023-01-31Sell1,77921.7538,6972023-02-02 19:04:53
TVTXTravere Therapeutics, Inc.Cline Christopher R.Chief Financial Officer2023-01-31Sell1,58821.7534,5422023-02-02 19:02:35
TVTXTravere Therapeutics, Inc.Dube Eric MChief Executive Officer2023-01-31Sell8,19622.25182,3612023-02-02 18:58:33
TVTXTravere Therapeutics, Inc.Calvin SandraSVP, Chief Accounting Officer2023-01-31Sell2,03121.8744,4192023-02-02 18:53:33
TVTXTravere Therapeutics, Inc.Calvin SandraSVP, Chief Accounting Officer2023-01-24Sell1,09721.8623,9762023-01-26 16:05:49
TVTXTravere Therapeutics, Inc.ROTE WILLIAM E.Senior Vice President, R&D2023-01-24Sell2,06221.5044,3332023-01-26 16:05:48
TVTXTravere Therapeutics, Inc.REED ELIZABETH ESVP, GC & Corporate Secretary2023-01-24Sell2,06221.5044,3332023-01-26 16:05:38
TVTXTravere Therapeutics, Inc.Dube Eric MChief Executive Officer2023-01-24Sell6,44221.50138,5032023-01-26 16:05:36
TVTXTravere Therapeutics, Inc.Cline Christopher R.Chief Financial Officer2023-01-24Sell85221.9018,6632023-01-26 16:05:28
TVTXTravere Therapeutics, Inc.Heerma PeterChief Commercial Officer2023-01-24Sell1,55021.9033,9522023-01-26 16:05:20
TVTXTravere Therapeutics, Inc.Dube Eric MChief Executive Officer2023-01-05Sell5,62520.75116,7192023-01-06 16:05:56
TVTXTravere Therapeutics, Inc.Inrig JulaChief Medical Officer2023-01-04Sell2,49320.7551,7302023-01-06 16:05:16